Cost of bladder cancer in Lebanon before and after the economic collapse: a probabilistic modeling study

Table 1 Costs of procedures (in thousands of LBP)

BCG, Bacille Calmette-Guérin; BDL, Banque du Liban; ddMVAC, Dose-Dense Methotrexate, Vinblastine, Adriamycin, Cisplatin; Gem, Gemcitabine; OOP, Out-Of-Pocket; LBP, Lebanese Pound; MMC, Mitomycin C; TAP, Thoraco-Abdomino-Pelvic; TMT, Tri-Modal Therapy; TPP, Third-Party Payers; TURBT, Transurethral Resection of Bladder Tumor
For each procedure, we collected the direct costs paid by TPPs and households, before and after the economic collapse. TPP and OOP payments were obtained by consulting the coverage databases of the various TPPs, taking into account the proportion of the Lebanese population covered by each TPP [15]. Drug costs were obtained from the Lebanese National Drug Database issued by the Ministry of Public Health [27]. In the post-collapse scenario, BDL subsidies amounted to 93% of drug prices at the time the modeling was performed

ISSN: 1475-9276